資源描述:
《肺絡(luò)寧合劑治療aecopd痰熱壅肺證的臨床療效觀察及對血清tnf-α、crp的影響》由會員上傳分享,免費(fèi)在線閱讀,更多相關(guān)內(nèi)容在學(xué)術(shù)論文-天天文庫。
1、提要目的:探討肺絡(luò)寧合劑治療AECOPD(慢性阻塞性肺病急性發(fā)作期)的臨床療效及對血清TNF-α、CRP水平變化的影響,探討血清TNF-α、CRP水平與AECOPD的關(guān)系。方法:將90例入選的AECOPD患者分為中藥組(A組30例),中藥加抗生素組(B組30例),抗生素組(C組30例)三組,A組入選對抗生素過敏的患者,B組C組隨機(jī)分配,中藥組采用肺絡(luò)寧合劑治療,中藥加抗生素組采用肺絡(luò)寧合劑加抗生素序貫療法治療,抗生素組采用抗生素治療,給藥2個周,觀察患者治療前后的癥狀、體征、血常規(guī)、肺功能、血?dú)饧把錞NF-α、CRP水平的改變。結(jié)果:三組患者治療后臨床評分均較治療前有顯著性降低(P<0.0
2、5),中藥加抗生素組明顯優(yōu)于中藥組和抗生素組(P<0.05),中藥組次之;三組患者癥候療效比較,中藥加抗生素組明顯優(yōu)于中藥組和抗生素組(P<0.05),中藥組次之;三組患者血常規(guī)、肺功能、血?dú)饨Y(jié)果均有所改善,以中藥加抗生素組最為明顯,中藥組次之;血清TNF-α、CRP水平均較前降低,中藥組、中藥加抗生素組明顯優(yōu)于抗生素組。結(jié)論:肺絡(luò)寧合劑能有效改善AECOPD患者臨床癥狀及體征,提高生存質(zhì)量;肺絡(luò)寧合劑能顯著改善患者血常規(guī),肺功能,血?dú)夥治鼋Y(jié)果;肺絡(luò)寧合劑可以下調(diào)患者血清TNF-α、CRP的水平;血清TNF-α參與AECOPD炎癥反應(yīng)過程,CRP水平能夠體現(xiàn)AECOPD炎癥反應(yīng)的程度,測定血
3、清中兩者的變化對病程分析、指導(dǎo)治療具有一定的臨床意義。關(guān)鍵詞肺絡(luò)寧合劑;AECOPD;臨床研究;TNF-α;CRPClinicalStudyontheefficacyoffeiluoningmixtureforphlegm-heatobstructinglungtypeAECOPDandtheeffectonthelevelsofTNF-α,CRPofserumSpeciality:TheresearchofLungDisease.MedicineofTCMAuthor:XingWeiTutor:ProfessorZhengXinAbstractObjective:Tostudythecli
4、nicalefficacyoffeiluoningmixtureforphlegm-heatobstructinglungtypeAcuteexacerbationofchronicobstructivepulmonarydisease(AECOPD)andtheeffectonthelevelsofTNF-α,CRPofserum,andfindouttherelationshipbetweenlevelsofTNF-α,CRPofserumandAcuteexacerbationofchronicobstructivepulmonarydisease.Methods:90casesofs
5、electedAcuteexacerbationofchronicobstructivepulmonarydisease(AECOPD)patientsweredividedintotraditionalchinesemedicinegroup(groupA30cases),traditionalchinesemedicineaddantibioticsgroup(groupB30cases),antibioticsgroup(groupC30cases)threegroups,groupAusingFeiluoningmixturetreatment,groupBusingFeiluoni
6、ngmixtureaddantibioticstreatment,groupCformedicinebyantibioticstreatment,2weeksaftertreatment,patientswereobservedtheclinicalsymptomsandsignschange.thebloodroutine,pulmonaryfunctionandarterybloodgasanalysischangeandTNF-α、CRPofthebloodchanged.Result:theclinicalscoreofthreegroupsaresignificantlylower
7、thanbefore(P<0.05),groupAandgroupCdonothaveobviousdifference(P>0.05),BgroupisbetterthanAandCgroup(P<0.05),Agroupisthesecond;thesymptomsefficacyofthreegroupsarecompared,BgroupisbetterthanAandCgroup(P<0.05),A